Biosino Bio-technology and Science Incorporation Announces Board Composition and Committee Roles

Bulletin Express
Feb 09

On 9 February 2026 in Beijing, the People’s Republic of China, Biosino Bio-technology and Science Incorporation released an announcement in which Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited declared they bear no responsibility for the contents. The announcement confirmed that the Board of Directors comprises three Executive Directors, one Non-executive Director, and three Independent Non-executive Directors: Chen Peng (Chairman and President), Li Zhonghua (Vice-Chairman), Chen Zhengyong, Kang Rui, Jin Tengchuan, Shen Jiangang, and Fan Xiaoliang.

The Audit Committee is led by Fan Xiaoliang as Chairman, with Jin Tengchuan and Shen Jiangang as members. The Nomination Committee is headed by Jin Tengchuan, while the Remuneration Committee is chaired by Shen Jiangang. Membership in these committees remains consistent with each Director’s respective designation within the Board.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10